Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01753700
Other study ID # B300
Secondary ID
Status Recruiting
Phase N/A
First received December 17, 2012
Last updated December 17, 2012
Start date December 2012
Est. completion date March 2013

Study information

Verified date December 2012
Source University of Copenhagen
Contact n/a
Is FDA regulated No
Health authority Denmark: The Ethical Comitee of Copenhagen
Study type Interventional

Clinical Trial Summary

The studie are to investigate the effect of ultra heat treated (UHT) versus pasteurised milk on bloodlipid profile


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date March 2013
Est. primary completion date March 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 22 Years to 50 Years
Eligibility Inclusion Criteria:

- healthy men and women

- 22-50 years of age

- BMI 25-30

- non smokers

Exclusion Criteria:

- lactose intolerance

- milk allergy or other types of food allergy

- Intestinal, abdominal or endocrinnologic diseases

- daily use of dietary supplements incl. vitamins and minerals

- cronic diseases (diabetes, CVD etc.)

- user of medicin on perscription that can influence the resuts of the study

- allergic to paraamino benzoe acid

- Physical activity > 10 h pr week

- Blood donor

- on a diet or change of dietary habits within 3 months

- body weigh change > 3 kg within the last 3 month

- special diets

- concomitant participation on other studies

- not able to comply with protocol

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms

  • To Investigate the Effect of UHT Treated Milk Versus Pasteurised Milk on Bloodlipid Profil

Intervention

Dietary Supplement:
UHT treated milk


Locations

Country Name City State
Denmark Department of Nutrition, Exercise and Sports Copenhagen Frederiksberg

Sponsors (4)

Lead Sponsor Collaborator
University of Copenhagen Arla Foods, Bionor Pharma, Hoeng Fonden

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Blood lipids 3 weeks No